Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
115 studies found for:    "Hepatic encephalopathy"
Show Display Options
Rank Status Study
1 Completed Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: placebo
2 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
3 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
4 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
5 Unknown  The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
6 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
7 Not yet recruiting Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Condition: Covert Hepatic Encephalopathy
Intervention: Drug: Rifaximin
8 Terminated
Has Results
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
9 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
10 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
11 Completed A Retrospective Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) (The RETRO Study)
Condition: Hepatic Encephalopathy
Intervention:
12 Completed Study of Rifaximin in Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: rifaximin
13 Completed Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: L-Ornithine L-Aspartate
14 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
15 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
16 Recruiting Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
17 Completed Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
18 Completed Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Biological: Lactobacillus GG;   Biological: Placebo
19 Unknown  ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3
20 Completed Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate;   Drug: Lactose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.